Effects of Ultrasound and Fluoroscopy guided injection in Ankylosing Spondylitis and related diseases.

Phase 1

Conditions: Health Condition 1: M45-M49- Spondylopathies

Registration Number: CTRI/2020/07/026854

Lead Sponsor: R G Kar Medical College and Hospital

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Diagnosed case of seronegative Spondyloarthropathy by ASAS criteria.

2. Pain primarily experienced between the upper level of the iliac crests and the gluteal fold.

3. Active sacroilitis clinically (positive finding of at least 3 of 6 following tests for SIJ pain)

i. Distraction or â??Gappingâ??

ii. FABER/Patrickâ??s Test

iii. Thigh Thrust or Posterior Pelvic Pain Provocational Test

iv. Gaenslenâ??s Test

v. Sacroiliac Joint Compression Test

vi. Sacral Thrust or Yeomanâ??s Test.

4. Poorly controlled by conservative treatment for 1 month by means of both pharmacological and non-pharmacological therapy.

5. Age between 18-45 years.

6. Oswestry disability index > 40%

7. NRS (0-10) > 5.

8. Reduction of pain intensity by > 75% following a diagnostic injection.

9. Unilateral sacroilitis.

Exclusion Criteria

1. Severe peripheral arthritis with hip involvement.

2. Clinical findings and imaging studies suggest other obvious cause of the pain (e.g., central spinal stenosis with neurogenic claudication/myelopathy, foraminal stenosis or disc herniation with concordant radicular pain/radiculopathy, pyriformis syndrome, infection, tumour, fracture, pain related to spinal instrumentation).

3. Degenerative sacroiliac joint or complete ankylosis of sacroiliac joint (Grade IV).

4. Patient assume prone lying position to be difficult.

5. Allergy to lignocaine, contrast dye.

6. Presence of coagulation disorder or receiving anti-coagulant therapy.

7. With other systemic disorders or active infection or other contraindications for corticosteroid injection.

8. Unwilling patient.

9. Patient unable to come to hospital for subsequent visits for follow-up.

10. Has current skin disease over the injection site.

11. Has psychiatric disorder.

12. H/o prior injection in SIJ within 2 months.